HRS Investmentssp. z o.o. + limited partnership
Dispensing chemist in specialised stores
Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 63 days early.
- 202509/07/2026
- 202403/04/2025
- 202327/03/2024
- 202206/07/2023
- 202129/06/2022
- 202004/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
HRS Investments has been an NFZ healthcare provider since 2018. In 2026 it is performing 8 contracts with a total value of USD 4.86k. All its contracts were worth USD 12.60k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | lubelskie | 4 | USD 4.09k |
| Pilot programmes | lubelskie | 3 | USD 769.85 |
| Provision of medical devices | lubelskie | 1 | USD 0.00 |
Partners
| Partners |
|---|
Paweł Rupećage 53 |
Sławomir Artur Szczygiełage 64 |
Manner of representation
The right to conduct the affairs of the partnership and represent it vis-à-vis third parties is vested in the general partner. In matters exceeding the scope of the ordinary activities of the partnership, the consent of the limited partners is not required. The general partner may make declarations of will, sign documents and conclude agreements on behalf of the partnership. The general partner is HRS INVESTMENTS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ, represented as follows: in the case of a one-person management board, declarations on behalf of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company. The management board of the general partner consists of Paweł Rupeć, President of the Management Board, and Sławomir Szczygieł, member of the management board.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-07-30.
Bank spółdzielczy59 8717 0009 2001 0001 2032 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
33 public aid cases recorded, with a total value of $51,729.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| May 26, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Apr 28, 2026 | Aid in the form of wage subsidies for employing workers with disabilities | $419$419 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl |
FAQ
Last updated: 2026-07-11